Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Antiepileptic drugs


In our subsection we conduct research on the efficacy and tolerability of new investigational drugs as well as different forms of vagus nerve stimulation for patients with epilepsy. Sometimes we have studies for newly diagnosed epilepsy, but mostly for patients with refractory epilepsy. Interest is also given to patients with specific epilepsy syndromes such as Dravets, Lennox-Gastaut and tuberous sclerosis as these patients are especially resistant to treatment alternatives.

Currently, there are two investigational drug studies in progress. One study is of a new medicine from Korea for patients with focal onset seizures and the other study is of a cannabidiol substance from the UK called Epidiolex.
Elinor Ben-Menachem has received the Lifetime Accelerator Award 2017 from the Epilepsy Foundation of America for the work done in this section to promote the development of successful new therapies for epilepsy.

In addition to these studies (and one to be commenced shortly) we are starting a study on the effects of cardiovascular fitness (exercise) or relaxation on patients with refractory focal epilepsy.

Publications

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

1996

Contact information

Photo of Elinor Ben-Menachem

Elinor Ben-Menachem

Guest professor

E-mail: elinor.ben-menachem@neuro.gu.se
Tel: +46 31-342 90 50

Page Manager: Katinka Almrén|Last update: 10/18/2018
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?